Symbiosis is a world class manufacturer specialising in cGMP sterile fill/finish of biopharmaceuticals for clinical trials and niche commercial markets including viral vector Advanced Therapeutics Medicinal Products (ATMPs). The competitive strengths of Symbiosis include MHRA and FDA-inspected standard regulatory compliance, expert technical capabilities and exceptional operational flexibility.
Incorporated in 2011, Symbiosis has specialist capabilities to support biotechnology and pharmaceutical clients who are developing either biologic or small molecule injectable drug products. One of the company’s key strengths is in accelerating the release of drug product which provides significant value by ensuring clients tight timelines are successfully met.
Manufacturing takes place in a first-class manufacturing facility, enabling Symbiosis to manufacture a broad range of liquid or lyophilized drug products including viral vectors, antibodies, proteins, peptides and small molecules in addition to the ability to handle cytotoxic anti-cancer drugs and antibody-drug conjugates.